{"id":275316,"date":"2026-09-28T14:58:26","date_gmt":"2026-09-28T09:28:26","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=275316"},"modified":"2026-09-28T14:58:26","modified_gmt":"2026-09-28T09:28:26","slug":"why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/","title":{"rendered":"Gujarat Themis Biosyn (GUJTHEM) Share Price Falls 5.18% Today; Stock Trades Below 50 DMA"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/gujthem\/gujarat-themis-biosyn-ltd-share-price-today\">Gujarat Themis Biosyn (GUJTHEM)<\/a> share price fell to Rs 395.7 today, down 5.18% from the previous close. Market cap was Rs 5,431.23 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;28 September 2026 at 2:53:24 PM IST<\/p>\n<p style=\"margin-top:0!important;\">Gujarat Themis Biosyn Share Price fell to Rs 395.7 today, down 5.18% from the previous close, with a market capitalisation of Rs 5,431.23 crore. The move places Gujarat Themis Biosyn in the Mid Cap category and makes today\u2019s decline relevant for investors following Gujarat Themis Biosyn Share Price Today, Gujarat Themis Biosyn Stock News and Gujarat Themis Biosyn Share Price Update. The supplied data confirms the price event, but it does not establish a company-specific catalyst. In that setting, Univest is tracking the move through price action, valuation and sector comparison so readers can place the decline in context rather than read too much into a single session. The stock\u2019s current price, day range and company ratios offer a factual base for Gujarat Themis Biosyn Share Price analysis.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#Gujarat_Themis_Biosyn_GUJTHEM_Share_Price_Today_Price_Action_Analysis\" title=\"Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis\">Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#Gujarat_Themis_Biosyn_GUJTHEM_Fundamental_Analysis\" title=\"Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis\">Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#Why_Investors_Are_Watching_Gujarat_Themis_Biosyn\" title=\"Why Investors Are Watching Gujarat Themis Biosyn\">Why Investors Are Watching Gujarat Themis Biosyn<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#About_Gujarat_Themis_Biosyn\" title=\"About Gujarat Themis Biosyn\">About Gujarat Themis Biosyn<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#Track_Gujarat_Themis_Biosyn_Share_Price_on_Univest\" title=\"Track Gujarat Themis Biosyn Share Price on Univest\">Track Gujarat Themis Biosyn Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#Why_did_Gujarat_Themis_Biosyn_Share_Price_fall_today\" title=\"Why did Gujarat Themis Biosyn Share Price fall today?\">Why did Gujarat Themis Biosyn Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#What_is_Gujarat_Themis_Biosyn_Share_Price_today\" title=\"What is Gujarat Themis Biosyn Share Price today?\">What is Gujarat Themis Biosyn Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#What_does_Gujarat_Themis_Biosyn_Share_Price_tell_investors\" title=\"What does Gujarat Themis Biosyn Share Price tell investors?\">What does Gujarat Themis Biosyn Share Price tell investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#How_does_Gujarat_Themis_Biosyn_compare_with_healthcare_peers\" title=\"How does Gujarat Themis Biosyn compare with healthcare peers?\">How does Gujarat Themis Biosyn compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#What_are_the_key_fundamentals_behind_Gujarat_Themis_Biosyn_Share_Price\" title=\"What are the key fundamentals behind Gujarat Themis Biosyn Share Price?\">What are the key fundamentals behind Gujarat Themis Biosyn Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-gujarat-themis-biosyn-share-price-price-fall-2026-09-28\/#What_should_readers_monitor_next_for_Gujarat_Themis_Biosyn_Share_Price\" title=\"What should readers monitor next for Gujarat Themis Biosyn Share Price?\">What should readers monitor next for Gujarat Themis Biosyn Share Price?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Gujarat_Themis_Biosyn_GUJTHEM_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 395.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 417.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 21.60 (-5.18%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 415.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 415.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 395.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.87 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,431.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Gujarat Themis Biosyn Share Price today shows a clear same-day decline from Rs 417.3 to Rs 395.7, a fall of Rs 21.6 or 5.18%. The stock opened at Rs 415.25, which was also the day high, and then moved to a day low of Rs 395.1. That leaves the close close to the lower end of the session range, but the supplied data only confirms the day\u2019s price path; it does not state why the move happened. The turnover was Rs 0.87 crore, which is a factual traded-value figure and should be read as context only. With a market capitalisation of Rs 5,431.23 crore, Gujarat Themis Biosyn remains a Mid Cap company. For readers searching Gujarat Themis Biosyn Share Price Fall or Gujarat Themis Biosyn Stock Falling Today, the key fact is that the stock ended below both its open and previous close. From here, the next step is to examine whether the move sits inside a broader valuation story in Gujarat Themis Biosyn Stock Analysis and Gujarat Themis Biosyn Share Price Today coverage.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Gujarat_Themis_Biosyn_GUJTHEM_Fundamental_Analysis\"><\/span><strong>Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,431.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">111.55x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.18x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3.74<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 80.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.16%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Gujarat Themis Biosyn has a market capitalisation of Rs 5,431.23 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 111.55x, P\/B at 5.18x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.41% and ROCE of 18.16%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 3.74, book value per share of Rs 80.59, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.87x, median ROE of 11.48%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">111.55x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.63x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.46x to 735.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.18x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.33x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.41%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,431.23 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 732.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,043.26 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the Healthcare sector and Pharmaceuticals &amp; Drugs industry, Gujarat Themis Biosyn Share Price can be compared with a benchmark set of 204 companies in the same industry. The company\u2019s P\/E of 111.55 is above the benchmark median of 32.87 and above the benchmark average of 49.63. Its P\/B of 5.18 is also above the benchmark median of 2.85 and above the average of 4.33. On profitability, ROE of 17.41% is above the industry median of 11.48% and the average of 10.04%, while ROCE of 18.16% is above the median of 13.17% and average of 12.82%. The industry market-cap median is Rs 732.57 crore and the average is Rs 14,043.26 crore, while Gujarat Themis Biosyn Market Cap is Rs 5,431.23 crore. That places Gujarat Themis Biosyn in the middle of the industry by size, but not by valuation. For sector analysis on Univest, the important point is that the price fall today sits against a backdrop of higher-than-benchmark valuation multiples and stronger-than-benchmark profitability ratios.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,55,115.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,613.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,19,899.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,875.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Peer comparison helps frame Gujarat Themis Biosyn Share Price against other listed pharmaceuticals names. Sun Pharmaceutical Industries has a P\/E of 36.77 and market cap of Rs 4,44,716.74 crore, while Divi\u2019s Laboratories trades at 87.22 times earnings with a Rs 2,55,115.31 crore market cap. Torrent Pharmaceuticals shows a P\/E of 86.94 and a larger P\/B of 21.13. Zydus Lifesciences has a P\/E of 26.57 and a P\/B of 4.45, both well below Gujarat Themis Biosyn\u2019s 111.55 and 5.18. Among the supplied peers, Gujarat Themis Biosyn is much smaller than the large-cap comparables but has a much richer earnings multiple than several names in the same industry. For Gujarat Themis Biosyn Share Price analysis, that difference matters because today\u2019s fall comes while the company still trades at a premium to many healthcare peers on P\/E and P\/B.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Gujarat_Themis_Biosyn\"><\/span><strong>Why Investors Are Watching Gujarat Themis Biosyn<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Gujarat Themis Biosyn Share Price fell 5.18% today to Rs 395.7.<\/li>\n<li>The stock opened at Rs 415.25 and touched a day low of Rs 395.1.<\/li>\n<li>Market capitalisation stands at Rs 5,431.23 crore and the company is classified as Mid Cap.<\/li>\n<li>P\/E is 111.55, P\/B is 5.18, ROE is 17.41% and ROCE is 18.16%.<\/li>\n<li>In the same industry, the benchmark median P\/E is 32.87 and the benchmark median P\/B is 2.85.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Gujarat_Themis_Biosyn\"><\/span><strong>About Gujarat Themis Biosyn<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gujarat Themis Biosyn operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied dataset identifies the company through its listed market profile, valuation ratios and return metrics, which are the key facts used in this article. For readers following Gujarat Themis Biosyn Company News and Gujarat Themis Biosyn Stock Performance, the most relevant verified points today are the current share price, market cap, earnings multiple and return ratios. Univest uses these company facts to keep the coverage tied to disclosed data rather than to assumptions. In practical terms, Gujarat Themis Biosyn Share Price becomes easier to read when it is assessed alongside the company\u2019s sector classification, market capitalisation and peer benchmark context.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Gujarat_Themis_Biosyn_Share_Price_on_Univest\"><\/span><strong>Track Gujarat Themis Biosyn Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/gujthem\/gujarat-themis-biosyn-ltd-share-price-today\">Gujarat Themis Biosyn (GUJTHEM) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Readers can track Gujarat Themis Biosyn Share Price on Univest for live price updates, company ratios, shareholding pattern, sector context, 52-week levels and market insights. Univest also brings together Gujarat Themis Biosyn Share Price Today, Gujarat Themis Biosyn Stock News and Gujarat Themis Biosyn Stock Analysis in one place so investors can review the latest factual data quickly.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Gujarat_Themis_Biosyn_Share_Price_fall_today\"><\/span><strong>Why did Gujarat Themis Biosyn Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The supplied data confirms that Gujarat Themis Biosyn Share Price fell 5.18% today to Rs 395.7, but it does not establish a company-specific catalyst. The decline is best read through the day\u2019s price action and valuation metrics.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Gujarat_Themis_Biosyn_Share_Price_today\"><\/span><strong>What is Gujarat Themis Biosyn Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Gujarat Themis Biosyn Share Price today is Rs 395.7. It moved down from the previous close of Rs 417.3, with a decline of Rs 21.6 during the session. Market capitalisation stands at Rs 5,431.23 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Gujarat_Themis_Biosyn_Share_Price_tell_investors\"><\/span><strong>What does Gujarat Themis Biosyn Share Price tell investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Gujarat Themis Biosyn Share Price shows a same-day decline, while the company still carries a P\/E of 111.55, P\/B of 5.18, ROE of 17.41% and ROCE of 18.16%. Those figures add important valuation context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Gujarat_Themis_Biosyn_compare_with_healthcare_peers\"><\/span><strong>How does Gujarat Themis Biosyn compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Gujarat Themis Biosyn trades at a higher P\/E and P\/B than peers such as Zydus Lifesciences and Cipla, while its market capitalisation is much smaller than Sun Pharma, Divi\u2019s Laboratories and Torrent Pharmaceuticals.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_fundamentals_behind_Gujarat_Themis_Biosyn_Share_Price\"><\/span><strong>What are the key fundamentals behind Gujarat Themis Biosyn Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The key fundamentals are market capitalisation of Rs 5,431.23 crore, EPS of Rs 3.74, book value of Rs 80.59 and dividend yield of 0.16%. The company also reports ROE of 17.41% and ROCE of 18.16%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_readers_monitor_next_for_Gujarat_Themis_Biosyn_Share_Price\"><\/span><strong>What should readers monitor next for Gujarat Themis Biosyn Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Readers should monitor the next disclosed price move, any fresh company updates, and whether the stock continues to trade at a premium valuation relative to the same-industry benchmark. Univest will continue to track the factual market data.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gujarat Themis Biosyn Share Price falls to Rs 395.7. marking a 5.18% fall today. Market cap stands at Rs 5,431.23 crore.<\/p>\n","protected":false},"author":29,"featured_media":275315,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-275316","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["275315"],"rank_math_title":["Gujarat Themis Biosyn Share Price Update: Price Fall Today"],"rank_math_description":["Gujarat Themis Biosyn Share Price fell 5.18% to Rs 395.7. Read on for price action, valuation, sector comparison and market context."],"rank_math_focus_keyword":["Gujarat Themis Biosyn Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/gujarat-themis-biosyn-gujthem-share-price-falls-5-18-today-stock-trades-below-50.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=275316"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275316\/revisions"}],"predecessor-version":[{"id":275317,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/275316\/revisions\/275317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/275315"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=275316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=275316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=275316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}